Identification of an ALK‐2 Inhibitor as an Agonist for Intercellular Exchange and Tumor Delivery of Nanomaterial is a research paper published in Advanced Therapeutics (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIBIB NIH HHS
Grant: R21 EB022652
NCI NIH HHS
Grant: R01 CA214550
NIGMS NIH HHS
Grant: R01 GM133885
National Institutes of Health
Grant: 7R21EB022652-03
Decoding the macropinocytic machinery for intracellular delivery of nanomaterials
National Institutes of Health
Grant: 5R01CA214550-05
Improving the in Vivo Delivery and Antitumor Efficacy of Antisense Drugs
Fields of Study
Keywords